摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

heptadecafluoro-1-azabicyclo<5,3,0>decane | 84818-81-5

中文名称
——
中文别名
——
英文名称
heptadecafluoro-1-azabicyclo<5,3,0>decane
英文别名
perfluoro-1-azabicyclo(5,3,0)decane;heptadecafluoro-1-azabicyclo[5,3,0]decane;Heptadecafluoro-1-azabicyclo[5.3.0]decane;1,1,2,2,3,3,5,5,6,6,7,7,8,8,9,9,9a-heptadecafluoropyrrolo[1,2-a]azepine
heptadecafluoro-1-azabicyclo<5,3,0>decane化学式
CAS
84818-81-5
化学式
C9F17N
mdl
——
分子量
445.079
InChiKey
VSWNBIICUATMJH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    128-129 °C
  • 密度:
    1.88±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    27
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    18

SDS

SDS:d00ae24a41685bb34b99b5ee2550301d
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Fluorinations with complex metal fluorides Part 8. Ring rearrangement in the fluorinations of quinoline with caesium tetrafluorocobaltate and with cobalt(III) fluoride
    作者:Raymond G. Plevey、Richard W. Rendell、John Colin Tatlow
    DOI:10.1016/s0022-1139(00)81454-2
    日期:1982.12
    similarly, but the only new product isolated was tridecafluoro-3-azabicyclo[4,4,0]deca- 1(6)-2-diene (R). The rearrangement occurring with quinoline prompted a re-examination of its fluorination by cobalt(III) fluoride. At ca. 350°, compound F was the major product, with very little E: there were some ring-opened materials, the most important being tetradecafluoro-4-pentafluoroethyl- 2-azaoct-2(Z)-ene (N)
    四氟钴酸铯在约350°时对喹啉进行氟化,主要得到五氟-2-氮杂双环[4,4,0] dec-1(2)-烯(E)和七氟-1-杂氮杂双[5,3]的混合物,0]由骨架重排产生的癸烷(F)。次要产物为六个多氟环己[b]-吡啶(GL),所有碳环均具有-(CF 2)4-部分。化合物F无反应性,但E对亲核试剂(例如水和甲醇)高度敏感。异喹啉类似地被氟化,但是分离出的唯一新产物是十三氟-3-氮杂双环[4,4,0]十-1(6)-2-二烯(R)。喹啉发生重排促使氟化钴(III)重新检查了其氟化程度。在约350°时,化合物F是主要产物,而E却很少:有一些开环的材料,最重要的是十四氟-4-五氟乙基-2-氮杂辛2(Z)-烯(N)。
  • Fluorinated polycyclic compounds
    申请人:ISC CHEMICALS LIMITED
    公开号:EP0368561A2
    公开(公告)日:1990-05-16
    A fully fluorinated and fully-saturated heterocyclic organic compound of general formula wherein the saturated rings F are fully fluorinated, and where the Rf radical is selected from perfluoro-alkyl groups, perfluoro-alicyclic groups, and mixed perfluoro-cycloalkyl-alkyl groups, and wherein the Rf radical contains from 1 to 10 carbon atoms inclusive.
    通式为全氟全饱和杂环有机化合物 其中饱和环 F 为全氟化,Rf 基选自全氟烷基、全氟脂环基和全氟环烷基-烷基混合基团,Rf 基含有 1 至 10 个碳原子(含 10 个)。
  • TATLOW, J. C.;PLEVEY, R. G.;WOTTON, D. E. M.;SARGENT, C. R.
    作者:TATLOW, J. C.、PLEVEY, R. G.、WOTTON, D. E. M.、SARGENT, C. R.
    DOI:——
    日期:——
  • US4562183A
    申请人:——
    公开号:US4562183A
    公开(公告)日:1985-12-31
  • US4935524A
    申请人:——
    公开号:US4935524A
    公开(公告)日:1990-06-19
查看更多

同类化合物

环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 吡咯并[1,2-a]氮杂-5-酮 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 (1R*,2E,11S*)-2-(cyclohexylmethylene)-1-(phenylsilyl)methyloctahydropyrrolo[1,2-a]azepine (R)-2-(6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]azepin-9-yl)-acetaldehyde curvulamine (3aR,8aS)-tert-butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride tert-butyl 6-(2-amino-2-oxoethyl)-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate 3-benzoyl-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-(tert-butyloxycarbonyl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethylazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethyl-6-methylazepino[4,5-b]indole (Z)-2,3,9,9a-tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-one 2,3,4,5,6,7-hexahydro-1H-3a,8,13,13b-tetraazabenzo[b]cyclopenta[1,2,3-jk]fluorene 2,3,4,5,6,7-hexahydro-1H-3a,8,11,11b-tetraazacyclohepta[1,2,3-jk]fluorene 1-Benzyloxy-2-methoxy-7,8,9,10-tetrahydro-6H-azepino<1,2-a>indole-11-carbaldehyde 3-benzoyl-10-(2-propoxyphenyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 2-phenyl-2,4,5,6-tetrahydro-1H-6-azabenzo[a]cyclohepta[cd]azulen-1-one 2-carbetoxy-3-(N,N-dimethyl)aminomethyleneamino-8-oxo-8H-4,5,6,7-tetrahydropyrrolo<2,3-c>azepine 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 5-(2-hydroxy-3-morpholin-4-yl-propyl)-3-methyl-4-oxo-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 11-(tert-butyldimethylsilyloxy)-1-trimethylsilyl-3a,4,11,12-tetrahydro-3H-cyclopenta[5,6]azepine[1,2-a]indole-2-one tert-butyl 8,9-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl 9,10-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl (1R,4S)-1-(benzylcarbamoyl)-3-oxo-2-((S)-1-phenylethyl)-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-4-ylcarbamate